Gregory Chinn

Dr. Gregory Chinn inspires change in the area of developmental neurotoxicity, with a particular focus on the effects of perinatal cannabinoid exposure on brain development. As an Assistant Professor of Anesthesia at the University of California, San Francisco, Dr. Chinn combines his expertise as a board-certified anesthesiologist with his passion for research to advance understanding in this critical field. His work is pivotal in identifying how early exposure to cannabinoids can impact neurodevelopment, potentially influencing future guidelines and practices in both clinical and research settings. At the Zuckerberg San Francisco General Hospital, Dr. Chinn practices anesthesia, where he applies his extensive knowledge to ensure patient safety and optimal outcomes. His clinical work is complemented by his research endeavors, which utilize a range of sophisticated techniques. These include animal behavior analysis, genomics, and neuronal ultrastructure analysis, all aimed at defining critical windows of sensitivity to drugs and elucidating the regulation of neurodevelopment by the endogenous cannabinoid system. Dr. Chinn's research contributions are well-recognized in the scientific community. He has published numerous studies on anesthetic neurotoxicity, shedding light on the potential risks and mechanisms involved. His work not only adds to the growing body of knowledge in this area but also informs the development of safer anesthetic practices, particularly for vulnerable populations such as pregnant women and young children. In addition to his research and clinical duties, Dr. Chinn has played a significant role in shaping expert opinion statements on preclinical research standards in the field of anesthetic neurotoxicity. His insights and recommendations are invaluable in guiding future research directions and ensuring that studies are conducted with the highest standards of scientific rigor. Dr. Chinn's dedication to his field is evident in his commitment to both education and mentorship. He actively engages with students and colleagues, fostering an environment of collaboration and innovation. Through his teaching and mentorship, he inspires the next generation of anesthesiologists and researchers to pursue excellence and contribute to the advancement of medical science. With a career marked by significant achievements and a steadfast commitment to improving patient care and safety, Dr. Gregory Chinn continues to be a leading figure in the field of anesthesia and developmental neurotoxicity research. His work not only enhances our understanding of the complexities of brain development but also paves the way for new approaches to anesthesia that prioritize long-term neurological health.